文献速递真菌感染

2009-2013年美国侵袭性曲霉病住院的流行病学与结局

Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013.
PubMed 文献 · Clin Infect Dis · 2018-01-01

基于美国医疗保健利用项目2009-2013年数据,在66634683例出院患者中识别出154888例(0.2%)侵袭性曲霉病(IA)。倾向评分匹配后,IA组死亡率(比值比1.43;95%置信区间1.36-1.51)和30天再入院率(1.39;1.34-1.45)均高于非IA组,IA与每例住院额外6.0天(95%置信区间5.7-6.4)和15542美元(13869-17215美元)额外费用相关。

要点

  • 高危人群中IA仍罕见,但IA组住院死亡率和30天再入院率均高于非IA组。
  • IA与每例住院额外6.0天住院时间和15542美元额外费用相关。
  • 美国每年近40000例IA住院,归因额外费用总计可能达6亿美元/年。

核心结论

  • 尽管在高危人群中仍属罕见,IA与住院死亡率升高、30天再入院率升高、住院时间延长及费用增加相关。
  • 鉴于美国每年近40000例IA住院,IA归因的额外费用总计可能达每年6亿美元。

研究设计与样本

  • 分析美国医疗保健研究与质量局医疗保健利用项目2009-2013年数据。
  • 在具有IA高危因素的对象中,通过国际疾病分类第九版临床修订码117.3、117.9和484.6识别IA。
  • 比较IA组与非IA组特征和结局,采用倾向评分匹配计算IA相关超额死亡率、30天再入院率、住院时间和费用。

主要发现

  • 66634683例符合研究纳入标准的出院患者中,154888例(0.2%)诊断为IA。
  • 非IA组最常见高危因素为大手术(50.1%),IA组为危重症(41.0%)。
  • 倾向评分匹配后,IA组死亡率高于非IA组(比值比1.43;95%置信区间1.36-1.51)。
  • 倾向评分匹配后,IA组30天再入院率高于非IA组(比值比1.39;95%置信区间1.34-1.45)。
  • IA与每例住院额外6.0天(95%置信区间5.7-6.4)和15542美元(95%置信区间13869-17215美元)额外费用相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Though invasive aspergillosis (IA) complicates care of up to 13% of patients with immunocompromise, little is known about its morbidity and mortality burden in the United States. METHODS: We analyzed the Health Care Utilization Project's data from the Agency for Healthcare Research and Quality for 2009-2013. Among subjects with high-risk conditions for IA, IA was identified via International Classification of Diseases, Ninth Revision, Clinical Modification codes 117.3, 117.9, and 484.6. We compared characteristics and outcomes between those with (IA) and without IA (non-IA). Using propensity score matching, we calculated the IA-associated excess mortality and 30-day readmission rates, length of stay, and costs. RESULTS: Of the 66634683 discharged patients meeting study inclusion criteria, 154888 (0.2%) had a diagnosis of IA. The most common high-risk conditions were major surgery (50.1%) in the non-IA and critical illness (41.0%) in the IA group. After propensity score matching, both mortality (odds ratio, 1.43; 95% confidence interval, 1.36-1.51) and 30-day readmission (1.39; 1.34-1.45) rates were higher in the IA group. IA was associated with 6.0 (95% confidence interval, 5.7-6.4) excess days in the hospital and $15542 ($13869-$17215) in excess costs per hospitalization. CONCLUSIONS: Although rare even among high-risk groups, IA is associated with increased hospital mortality and 30-day readmission rates, excess duration of hospitalization, and costs. Given nearly 40000 annual admissions for IA in the United States, the aggregate IA-attributable excess costs may reach $600 million annually.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zilberberg MD, Nathanson BH, Harrington R, et al. Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013. Clin Infect Dis. 2018. PMID: 29718296. doi:10.1093/cid/ciy181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。